Literature DB >> 26633132

The critical role of IL-6 in the pathogenesis of Takayasu arteritis.

Xiufang Kong1, Ying Sun1, Lili Ma1, Huiyong Chen1, Lei Wei1, Wanlong Wu1, Zongfei Ji1, Lingying Ma1, Zhuojun Zhang1, Zhigang Zhang2, Zhonghua Zhao2, Jun Hou3, Shengming Dai4, Chengde Yang5, Lindi Jiang6.   

Abstract

OBJECTIVES: To investigate T cell subsets and immune cytokine profiles in untreated Takayasu arteritis (TAK) patients and the underlying immunopathological mechanism.
METHODS: We enrolled 50 untreated TAK patients and 40 age-matched controls (20 healthy controls, 20 untreated SLE patients). Enzyme-linked immunosorbent assays (ELISAs) were used to define cytokine profiles in all patients, and flow cytometry was performed for 9 TAK patients and 12 healthy controls. Hematoxylin and eosin (Handamp;E) staining and immunohistochemistry (IHC) were performed in aortic tissues of 9 TAK and 9 atherosclerosis patients; clinical data were also collected.
RESULTS: Circulating CD4(+) T cells were more frequent in TAK patients (p<0.05). Frequencies of Th1, Th2, and Th17 cells were higher, whereas Treg cells were reduced in TAK. Significantly higher levels of IL-6 and lower levels of IFN-γ, IL-4, and IL-17 were detected in TAK patients (p<0.05). By H & E staining, thickened vascular walls with proliferation of collagen fibre were observed in most patients. Inflammatory sites with infiltrating macrophages, lymphocytes, and neutrophils were located in adventitia. IHC revealed T cells (mainly CD4(+) T cells) in vascular lesions. Additionally, IL-6 was positive throughout the vascular wall in most specimens, whereas IFN-γ, IL-12, and IL-17 were detected in inflammatory sites of active patients. IL-6 levels were positively related to ESR, CRP, and Kerr scores (p<0.05).
CONCLUSIONS: Significantly increased levels of IL-6 were detected in peripheral blood and aortic tissues of untreated patients. IL-6 might be a sensitive biomarker to assess disease activity and could be critical in the immunopathogenesis of TAK.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26633132

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  31 in total

1.  Associations between clinical features and therapy with macrophage subpopulations and T cells in inflammatory lesions in the aorta from patients with Takayasu arteritis.

Authors:  J P Dos Santos; R Artigiani Neto; C L P Mangueira; R Z Filippi; P S Gutierrez; J Westra; E Brouwer; A W S de Souza
Journal:  Clin Exp Immunol       Date:  2020-07-30       Impact factor: 4.330

2.  18F-FDG-PET/CT: an accurate method to assess the activity of Takayasu's arteritis.

Authors:  Xiaojie Zhang; Jun Zhou; Ying Sun; Hongcheng Shi; Zongfei Ji; Lindi Jiang
Journal:  Clin Rheumatol       Date:  2018-01-03       Impact factor: 2.980

Review 3.  Takayasu Arteritis: Recent Developments.

Authors:  Maria L F Zaldivar Villon; Jose A Leon de la Rocha; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2019-07-18       Impact factor: 4.592

4.  Nephrotic range proteinuria and metabolic alkalosis in Takayasu arteritis.

Authors:  Takahiro Tsuchida; Hiroyuki Yano; Yoshihiko Raita; Mitsuyo Kinjo
Journal:  BMJ Case Rep       Date:  2019-04-15

5.  Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.

Authors:  Lili Pan; Juan Du; Jiayi Liu; Hua Liao; Xiaoli Liu; Xi Guo; Jing Liang; Hongya Han; Lixia Yang; Yujie Zhou
Journal:  Clin Rheumatol       Date:  2020-03-06       Impact factor: 2.980

Review 6.  Mechanism and biomarkers in aortitis--a review.

Authors:  Benjamin Benhuri; Ammar ELJack; Bashar Kahaleh; Ritu Chakravarti
Journal:  J Mol Med (Berl)       Date:  2019-10-30       Impact factor: 4.599

7.  The value of interleukin-6 in predicting disease relapse for Takayasu arteritis during 2-year follow-up.

Authors:  Ying Sun; Xiufang Kong; Xiaomeng Cui; Xiaomin Dai; Lili Ma; Huiyong Chen; Rongyi Chen; Peng Lv; Jiang Lin; Qingrong Huang; Xuejuan Jin; Lindi Jiang
Journal:  Clin Rheumatol       Date:  2020-05-09       Impact factor: 2.980

Review 8.  Interleukin-2 and regulatory T cells in rheumatic diseases.

Authors:  Antonios G A Kolios; George C Tsokos; David Klatzmann
Journal:  Nat Rev Rheumatol       Date:  2021-11-02       Impact factor: 20.543

9.  Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab.

Authors:  Kazusato Hara; Masataka Umeda; Keiko Segawa; Midori Akagi; Yushiro Endo; Tomohiro Koga; Shin-Ya Kawashiri; Kunihiro Ichinose; Hideki Nakamura; Takahiro Maeda; Atsushi Kawakami
Journal:  Intern Med       Date:  2021-10-05       Impact factor: 1.282

10.  Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis.

Authors:  Xiufang Kong; Ming Xu; Xiaomeng Cui; Lingying Ma; Huiyong Cheng; Jun Hou; Xiaoning Sun; Lili Ma; Lindi Jiang
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.